bpc-157 fda warning news 2025 october adcomm votes in favor of lifting restrictions on popular wellness peptide FDA moves toward easing restrictions
FDA moves toward easing restrictions on certain peptides BioPharma Dive On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a Warning Letter to Platinum Biologics LLC for marketing umbilicalcordderived products including exosome products (NanoEx & Nano Xsomes) without approval. This Week at FDA: New international partnerships, UniQure and Moderna reversals, and more RAPS Is BPC 157 Banned? Oral vs. Injectable Forms Explained BPC 157 Banned: Key Facts on the Latest FDA Decision Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related Therapeutics
Pay in 4 interest-free payments of $5.19 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4




